Chemoinformaics analysis of 13-Isovaleroyloxylupanine
| Molecular Weight | 348.487 | nRot | 3 |
| Heavy Atom Molecular Weight | 316.231 | nRig | 22 |
| Exact Molecular Weight | 348.241 | nRing | 4 |
| Solubility: LogS | -3.036 | nHRing | 4 |
| Solubility: LogP | 2.648 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 59.3434 |
| nHD | 0 | BPOL | 38.9946 |
| QED | 0.735 |
| Synth | 4.703 |
| Natural Product Likeliness | 1.126 |
| NR-PPAR-gamma | 0.036 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.562 |
| HIA | 0.003 |
| CACO-2 | -4.76 |
| MDCK | 0.0000297 |
| BBB | 0.44 |
| PPB | 0.203466 |
| VDSS | 1.099 |
| FU | 0.67941 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.047 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.366 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.309 |
| CYP2d6-inh | 0.561 |
| CYP2d6-sub | 0.36 |
| CYP3a4-inh | 0.213 |
| CYP3a4-sub | 0.566 |
| CL | 14.428 |
| T12 | 0.524 |
| hERG | 0.054 |
| Ames | 0.005 |
| ROA | 0.005 |
| SkinSen | 0.959 |
| Carcinogencity | 0.473 |
| EI | 0.03 |
| Respiratory | 0.186 |
| NR-Aromatase | 0.012 |
| Antiviral | Yes |
| Prediction | 0.794171 |